Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Oncotarget|October 2, 2015
Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: a case reportJad Alshami, Marie-Christine Guiot, Scott Owen, et al.Cureus|January 17, 2017
Pattern of Local Recurrence and Distant Metastasis in Breast Cancer By Molecular SubtypeXingrao Wu, Ayesha Baig, Goulnar Kasymjanova, et al.Oncotarget|June 2, 2016
A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapyPhilip Wong, Ilana R Leppert, David Roberge, et al.Journal of Neurosurgery|March 17, 2009
Low-grade oligodendroglioma: an indolent but incurable disease? Clinical articleHamdy El-Hateer, Luis Souhami, David Roberge, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 2, 2022
Neuronal GPR81 regulates developmental brain angiogenesis and promotes brain recovery after a hypoxic ischemic insultPrabhas Chaudhari, Ankush Madaan, José Carlos Rivera, et al.Breast Cancer Research and Treatment|September 20, 2021
Population-based analysis of non-operative management and treatment patterns in older women with estrogen receptor-positive breast cancerDavid Tejera, Mariam Rana, Mark Basik, et al.Cancer Research|February 3, 2006
Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysisCynthia Ménard, Donald Johann, Mark Lowenthal, et al.International Journal of Radiation Oncology, Biology, Physics|June 17, 2008
Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysisValerie Panet-Raymond, Luis Souhami, David Roberge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapyLinda W Chan, Marsha A Moses, Elizabeth Goley, et al.Oncotargets and Therapy|April 15, 2022
Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to AfatinibScott Owen, Scheryll Alken, Jad Alshami, et al.Pageof 4